GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dannex Ayrton Starwin PLC (XGHA:DASPHARMA) » Definitions » Debt-to-Asset

Dannex Ayrton Starwin (XGHA:DASPHARMA) Debt-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Dannex Ayrton Starwin Debt-to-Asset?

Dannex Ayrton Starwin's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was GHS0.00 Mil. Dannex Ayrton Starwin's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was GHS0.00 Mil. Dannex Ayrton Starwin's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was GHS0.00 Mil.


Dannex Ayrton Starwin Debt-to-Asset Historical Data

The historical data trend for Dannex Ayrton Starwin's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dannex Ayrton Starwin Debt-to-Asset Chart

Dannex Ayrton Starwin Annual Data
Trend
Debt-to-Asset

Dannex Ayrton Starwin Semi-Annual Data
Debt-to-Asset

Competitive Comparison of Dannex Ayrton Starwin's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Dannex Ayrton Starwin's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dannex Ayrton Starwin's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dannex Ayrton Starwin's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Dannex Ayrton Starwin's Debt-to-Asset falls into.



Dannex Ayrton Starwin Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Dannex Ayrton Starwin's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Dannex Ayrton Starwin's Debt-to-Asset for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dannex Ayrton Starwin  (XGHA:DASPHARMA) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Dannex Ayrton Starwin Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Dannex Ayrton Starwin's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Dannex Ayrton Starwin Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.

Dannex Ayrton Starwin Headlines

No Headlines